<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">391</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2020-19-3-114-120</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>ШКОЛА ИММУНОЛОГА</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">A rare case of combined immunodeficiency due to a deletion of 11(q) – Jacobsen syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Редкий случай комбинированного иммунодефицита с делецией длинного плеча хромосомы 11(q) – синдром Якобсена</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1669-8621</contrib-id><name-alternatives><name xml:lang="en"><surname>Kuzmenko</surname><given-names>N. B.</given-names></name><name xml:lang="ru"><surname>Кузьменко</surname><given-names>Н. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, the Head of the Department of Epidemiology and Monitoring of Immunodeficiencies, </p><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>канд. мед. наук, заведующая отделом эпидемиологии и мониторинга иммунодефицитов, врач-аллерголог-иммунолог консультативного отделения,</p><p>117997, Москва, ул. Саморы Машела, 1 </p></bio><email>plunge@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5347-7150</contrib-id><name-alternatives><name xml:lang="en"><surname>Shvets</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Швец</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3305-1694</contrib-id><name-alternatives><name xml:lang="en"><surname>Mukhina</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Мухина</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-09-08" publication-format="electronic"><day>08</day><month>09</month><year>2020</year></pub-date><volume>19</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>114</fpage><lpage>120</lpage><history><date date-type="received" iso-8601-date="2020-10-06"><day>06</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-10-06"><day>06</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/391">https://hemoncim.com/jour/article/view/391</self-uri><abstract xml:lang="en"><p>Jacobsen syndrome (JS) is a rare combined immunodeficiency caused by partial deletion of the long arm of chromosome 11. Clinical features include physical growth retardation, psychomotor retardation, characteristic facial dysmorphism (skull deformities, hypertelorism, ptosis, coloboma, epicanthal folds, broad nasal bridge, short nose, v-shaped mouth, small low set ears). Patients commonly have malformations of the heart, kidney, gastrointestinal tract, genitalia, central nervous system and skeleton. Abnormal platelet function and immunological problems are usually present. Here we describe a patient with deletion of 11(q) chromosome resulting in clinical phenotype of the facial dysmorphisms, congenital malformations, neurological symptoms, as well as clinical and laboratory features of immunodeficiency. Features of immune dysregulation in a patient with JS are clearly characterized. Patient's parents agreed to use personal dats and photos in research and publications.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром Якобсена (СЯ) – редкий комбинированный иммунодефицит, связанный с частичной делецией длинного плеча 11-й хромосомы. Клинические проявления данного заболевания включают задержку физического и умственного развития, дисморфизм лица (деформации черепа, гипертелоризм, птоз, колобому, эпикантальные складки, широкую переносицу, маленький нос, V-образный рот, маленькие низко посаженные уши), пороки развития сердца, почек, желудочнокишечного тракта, гениталий, центральной нервной системы и скелета, а также нарушение функции тромбоцитов, гуморального и клеточного звеньев иммунной системы. В статье приведено клиническое наблюдение пациентки с СЯ с делецией хромосомы 11(q) и клиническим фенотипом, включающим дисморфизмы лица, врожденные пороки развития, неврологическую симптоматику, а также клинические и лабораторные проявления иммунодефицита, четко охарактеризованы проявления дисрегуляции. Родители пациентки дали согласие на использование информации, в том числе фотографий ребенка, в научных исследованиях и публикациях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Jacobsen syndrome</kwd><kwd>del 11(q)</kwd><kwd>combined immunodeficiency</kwd><kwd>immune dysregulation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром Якобсена</kwd><kwd>делеция хромосомы 11(q)</kwd><kwd>комбинированный иммунодефицит</kwd><kwd>иммунная дисрегуляция</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Mattina T., Perrotta C.S., Grossfeld P. Jacobsen syndrome. Orphanet J Rare Dis 2009; 4: 9. DOI: 10.1186/1750-1172-4-9</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Favier R., Akshoomoff N., Mattson S., Grossfeld P. Jacobsen syndrome: advances in our knowledge of phenotype and genotype. Am J Med Genet C Semin Med Genet 2015; 169 (3): 239–50. DOI: 10.1002/ajmg.c.31448</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bernaciak J., Szczaluba K., Derwinska K., Wiśniowiecka-Kowalnik B., Bocian E., Sasiadek M.M., et al. Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11) (q24.3). Am J Med Genet A 2008; 146A (19): 2449–54. DOI: 10.1002/ajmg.a. 32490</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Jacobsen syndrome. Genetics Home Reference (GHR): [Электронный ресурс]. 2009. URL: http://ghr.nlm.nih.gov/condition/jacobsen-syndrome. (Дата обращения 28.07.2020).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kang S.H., Shaw C., Ou Z., Eng P.A., Cooper M.L., Pursley A.N., et al. Insertional translocation detected using FISH confirmation of array-comparative genomic hybridization (aCGH) results. Am J Med Genet A 2010; 152A: 1111–26. DOI: 10.1002/ajmg.a.33278</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ellison J.W., Ravnan J.B., Rosenfeld J.A., Morton S.A., Neill N.J., Williams M.S., et al.. Clinical utility of chromosomal microarray analysis. Pediatrics 2012; 130: e1085–95. DOI: 10.1542/peds.2012- 0568</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hill A.S., Foot N.J., Chaplin T.L., Young B.D. The most frequent constitutional translocation in humans, the t(11;22)(q23;q11) is due to a highly specific alu-mediated recombination. Hum Mol Genet 2000; 9 (10): 1525–32. DOI: 10.1093/hmg/9.10.1525</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jones C., Mullenbach R., Grossfeld P., Auer R., Favier R., Chien K., et al. Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: Evidence for a common mechanism of chromosome breakage. Hum Mol Genet 2000; 9 (8): 1201–8. DOI: 10.1093/hmg/9.8.1201</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Takahashi I., Takahashi T., Sawada K., Shimojima K., Yamamoto T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identified at age 40 years. Am J Med Genet A 2012; 158A (1): 220–3. DOI: 10.1002/ajmg.a.34382</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Blazina S., Lovrečić L., Hovnik T. 11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome. Am J Med Genet A 2016; 170 (12): 3237–40. DOI: 10.1002/ajmg.a.37859</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gao Z., Kim G.H., Mackinnon A.C., Flagg A.E., Bassett B., Earley J.U., Svensson E.C. Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development 2010; 137 (9): 1543–51. DOI: 10.1242/dev.047696</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Garrett-Sinha L.A. Review of Ets1 structure, function, and roles in immunity. Cell Mol Life Sci 2013; 70 (18): 3375–90. DOI: 10.1007/s00018-012-1243-7</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Seppänen M., Koillinen H., Mustjoki S., Tomi M., Sullivan K.E. Terminal Deletion of 11q with Significant Late-Onset Combined Immune Deficiency. J Clin Immunol 2014; 34 (1): 114–8. DOI: 10.1007/s10875-013-9966-2</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hart A., Melet F., Grossfeld P., Chien K., Jones C., Tunnacliffe A., et аl. Fli‐1 is required for murine vascular and megakaryocytic development and is homozygously deleted in patients with thrombocytopenia. Immunity 2000; 13 (2): 167–77. DOI: 10.1016/s1074-7613(00)00017-0</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ye M., Coldren C., Benson W., Goldmuntz E., Ostrowski M., Watson D., et аl. Deletion of ETS‐1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet 2010; 19 (4): 648– 56. DOI: 10.1093/hmg/ddp532</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Grossfeld P.D., Mattina T., Lai Z., Favier R., Jones K.L., Cotter F., Jones C. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 2004; 129A (1): 51–61. DOI: 10.1002/ajmg.a.30090</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sakkou M., Wiedmer P., Anlag K., Hamm A., Seuntjens E., Ettwiller L., et al. A role for brain‐specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metab 2007; 5 (6): 450–63. DOI: 10.1016/j.cmet.2007.05.007</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Pak J.H., Huang F.L., Li J., Balschun D., Reymann K.G., Chiang C., et al. Involvement of neurogranin in the modulation of calcium/calmodulin‐dependent protein kinase II, synaptic plasticity, and spatial learning: A study with knockout mice. Proc Natl Acad Sci U S A 2000; 97 (21): 11232–7. DOI: 10.1073/pnas.210184697</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Nasu‐Nishimura Y., Hayashi T., Ohishi T., Okabe T., Ohwada S., Hasegawa Y., et al. Role of the Rho GTPase‐ activating protein RICS in neurite outgrowth. Genes Cells 2006; 11 (6): 607–14. DOI: 10.1111/j.1365-2443.2006.00966.x</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Penny L.A., Dell’Aquila M., Jones M.C., Bergoffen J., Cunniff C., Fryns J.P., et al. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet 1995; 56 (3): 676–83.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Krishnamurti L., Neglia J.P., Nagarajan R., Berry S.A., Lohr J., Hirsch B., White J.G. Paris‐Trousseau syndrome platelets in a child with Jacobsen's syndrome. Am J Med Haematol 2001; 66 (4): 295–99. DOI: 10.1002/ajh.1061</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tangye S.G., Al-Herz W., Bousfiha A., Chatila T., Cunningham-Rundles C., Etzioni A., et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2020; 40 (1): 24–64. DOI: 10.1007/s10875-019-00737-x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sirvent N., Monpoux F., Pedeutour F., Fraye M., Philip P., Ticchioni M., et al. Jacobsen syndrome, thrombopenia, and humoral immunodeficiency. Arch Pediatr 1998; 5 (12): 1338–40. DOI: 10.1016/s0929-693x(99)80052-9</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Dalm V.A., Driessen G.J., Barendregt B.H., van Hagen P.M., van der Burg M. The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency. J Clin Immunol 2015; 35 (8): 761–8. DOI: 10.1007/s10875-015-0211-z</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Fernandez-San Jose C., Martin-Nalda A., Vendrell Bayona T., Soler-Palacín P. Hypogammaglobulinemia in a 12-yearold patient with Jacobsen syndrome. J Paediatr Child Health 2011; 47 (7): 485–6. DOI: 10.1111/j.1440-1754.2011.02136.x</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Puglisi G., Netravali M.A., MacGinnitie A.J., Bonagura V.R. 11q terminal deletion disorder and common variable immunodeficiency. Ann Allergy Asthma Immunol 2009; 103 (3): 267–8. DOI: 10.1016/S1081-1206(10)60192-5</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Verbsky J.W., Baker M.W., Grossman W.J., Hintermeyer M., Dasu T., Bonacci B., et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008–2011). J Clin Immunol 2012; 32 (1): 82–8. DOI: 10.1007/s10875-011-9609-4</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>von Bubnoff D., Kreiss-Nachtsheim M., Novak N., Engels E., Engels H., Behrend C. et al. Primary immunodeficiency in combination with transverse upper limb defect and anal atresia in a 34-year-old patient with Jacobsen syndrome. Am J Med Genet A 2004; 126A (3): 293–8. DOI: 10.1002/ajmg.a.20592</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>So J., Stockley T., Stavropoulos D.J. Periventricular nodular heterotopia and transverse limb reduction defect in a woman with interstitial 11q24 deletion in the Jacobsen syndrome region. Am J Med Genet A 2014; 164A (2): 511–5. DOI: 10.1002/ajmg.a.36292</mixed-citation></ref></ref-list></back></article>
